Overview

Mebendazole as Adjuvant Treatment for Colon Cancer

Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
mebendazole treating colon cancer
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Bevacizumab
DMP 777
Mebendazole
Piperazine
Piperazine citrate